A group of eight reporting persons led by Michael Bigger filed Amendment No. 12 to a Schedule 13G with the SEC on November 3, 2026, disclosing their combined beneficial ownership in ClearPoint Neuro, Inc. (NASDAQ:CLPT), a medical technology company whose common stock carries a $0.01 par value and is identified by CUSIP 18507C103.

Key Highlights

  • Michael Bigger's aggregate position: Michael Bigger beneficially owned 2,601,255 shares, representing 8.12% of ClearPoint Neuro's outstanding common stock, as of November 3, 2026.
  • Bigger Capital Fund LP holding: Bigger Capital Fund LP reported beneficial ownership of 1,707,447 shares, representing 5.33% of the class, with all voting and dispositive power shared.
  • District 2 Capital Fund LP holding: District 2 Capital Fund LP reported beneficial ownership of 315,808 shares, with 0% of class listed for each of the District 2 entities.
  • Patricia Winter position: Reporting person Patricia Winter disclosed sole voting and dispositive power over 167,000 shares, representing 0% of the class.
  • Amendment number: This filing is Amendment No. 12, indicating a series of prior disclosures regarding this issuer.
  • Triggering date: The event requiring the filing occurred on September 30, 2026, according to the document.

Beneficial Ownership Details Across the Bigger and District 2 Reporting Group

According to the filing, eight entities and individuals are collectively named as reporting persons. Bigger Capital Fund LP, a Delaware limited partnership based in Las Vegas, Nevada, reported 1,707,447 shares with shared voting and shared dispositive power, and no sole power over any shares. Its general partner, Bigger Capital Fund GP, LLC, is deemed to beneficially own the same 1,707,447 shares on the same basis, as stated in the filing.

Michael Bigger, a U.S. citizen listed at the same Las Vegas address, reported an aggregate beneficial ownership of 2,601,255 shares. Of those, 55,000 shares are held with sole voting and sole dispositive power, while 2,546,255 shares are held with shared voting and shared dispositive power, according to the document. This combined position represents 8.12% of ClearPoint Neuro's outstanding common stock class.

The District 2 entities, all Delaware-organized and based in Huntington, New York, each report 315,808 shares beneficially owned, entirely on a shared basis, with no sole voting or dispositive power. The filing identifies District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, and District 2 Holdings LLC as the relevant parties within that group. Patricia Winter, also a U.S. citizen at the Las Vegas address, reported 167,000 shares with sole voting and dispositive power and no shared interest. ClearPoint Neuro, Inc. is headquartered at 120 S. Sierra Avenue, Suite 100, Solana Beach, CA, 92075, according to the filing.

What Was Disclosed

The filing disclosed the beneficial ownership positions of eight reporting persons in ClearPoint Neuro common stock as of November 3, 2026, with the triggering event dated September 30, 2026. Michael Bigger held the largest individual position at 8.12% of the class, totaling 2,601,255 shares.